false
Catalog
HRX 2024 AbstracX Library
Identifying Acute Myocardial Infarction Early Clin ...
Identifying Acute Myocardial Infarction Early Clinical Utility
Back to course
Pdf Summary
The document discusses the development and clinical utility of a 12-lead ECG synthesized from a single touch of a wrist-worn device for the early identification of acute myocardial infarction (AMI). The problem identified is the delayed diagnosis and treatment of AMI, which significantly increases mortality rates. The document highlights that timely intervention is critical, as mortality risk increases by 8% for every half-hour delay in treatment.<br /><br />To address this, the proposed solution involves using a wrist-worn device to acquire two ECGs. These ECGs are then processed using an echo state network to synthesize a 12-lead ECG automatically. This synthesized ECG can be analyzed both automatically and manually for diagnosis purposes.<br /><br />An evaluation of this method was conducted with 54 participants and involved four cardiologists in a blind study. The focus was on assessing the sensitivity and specificity of AMI diagnosis and the intra-rater agreement between the clinical and synthesized ECGs. Although specific data points such as sensitivity, specificity, and agreement rates were not disclosed in the document, the implication is that the synthesized ECG has shown promise in accurately diagnosing AMI.<br /><br />The work is supported by the Research Council of Lithuania, highlighting its scientific merit and potential applicability in medical practice for enhancing early detection and reducing treatment delays for AMI.<br /><br />Overall, this study could pave the way for more widespread use of wearable technology in immediately diagnosing cardiac events, potentially saving lives by preventing treatment delays through rapid and accessible ECG analysis.
Keywords
12-lead ECG
wrist-worn device
acute myocardial infarction
AMI diagnosis
echo state network
synthesized ECG
cardiology
wearable technology
early detection
mortality reduction
HRX is a Heart Rhythm Society (HRS) experience. Registered 501(c)(3). EIN: 04-2694458.
Vision:
To end death and suffering due to heart rhythm disorders.
Mission:
To Improve the care of patients by promoting research, education, and optimal health care policies and standards.
© Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
×
Please select your language
1
English